We would love to hear your thoughts about our site and services, please take our survey here.
@dp192 - ALL 79 Mothercare Stores closed at the beginning of January 2020 when it went into administration. Online business continued and a very few stores have since re-opened with the same name but completely different owner.
@bigAl67: Thanks for the insight (as I don't have access to trade data) although I'm not sure how you can be certain on your buy and sell figures as they are only a 'guess' based on the mid price and I have bought many a share below the mid price and sold many a share above the mid price! I was simply going on the fact that I couldn't get a sell quote for a long time and only on a very small number (100) and when I finally got a sell quote for a larger quantity the price had slipped quite a bit. As far as I'm aware that's usually what happens when there's not much demand and this is sometimes due to the fact that there is a glut of shares available (because people have decided to sell en masse.)
@JimiHendrix: I appreciate it's 'just the free service' but surely that's the key point as NHS Trusts are unlikely to have the resources to continue the programme on a sef-funding basis? Did you read the whole article and the Consultant's comment at the end of this paragraph:
' The Independent has also been told that the NHS now has an excess of Lamp supplies, with UKHSA officials and private consultants now working to recoup some of the high costs spent on the tests. As well as seeking to sell the testing devices to individual trusts, officials are also looking at selling the extra supplies overseas. “We bought all this Lamp, but it’s not a priority for anyone,” said one consultant working with the UKHSA.'
UKHSA have been informed that LAMP testing programme is to end on 30th June 2022 (Ministerial letter leaked to Independent) https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.independent.co.uk/news/health/fear-variants-covid-testing-b2014908.html%3Famp&ved=2ahUKEwitsZvYvYb2AhXlmFwKHR1vDA0QFnoECAUQAQ&usg=AOvVaw3zwfcECzkSDp4lPu_Z3RLc
" In a letter to all NHS trusts and laboratories on the 2 February, seen by The Independent, the UKHSA said the Lamp scheme would have to cease by 30 June. NHS trusts wanting to continue with the programme will have to pay for it themselves." Apologies if this has already been posted.
Knowing that Novacyt CTDA has taken almost half a year does not fill me with confidence but I can't even get a quote to sell a mere 5000 GDR shares at the moment with HL. I have just tried selling 1000 and can't get a quote for that. I am worried that everyone is offloading and that I'll be stuck with 100000 shares that I can't get rid of!
Freedom of Information Request.
Dear Sir or Madam,
Under the Freedom of Information Act 2000, please provide me with copies of the following:
1. Between the 1st November 2021 and 31st January 2022, how many applications for CTDA Approval have you received in total?
2. Of that total number of applications received between 1st November 2021 and 31st Jan 2022 (point 1. above)
a) What number/percentage are awaiting commencement of the process (backlog/queued up)?
b) What number/percentage have been rejected immediately upon submission/start of process?
c) What number/percentage have necessitated requisition for additional information?
d) What number/percentage are ‘in process’? (EXCLUDING backlog applications that have not commenced.)
e) What number/percentage are fully processed with a decision issued? (see point 3. below)
3. Of those applications in e) above, (fully processed with a decision issued,)
a) What number/percentage were awarded CTDA Approval?
b) What number/percentage were refused CTDA Approval?
4. Of those applicants that were awarded CTDA Approval (3a above)
a) What number/percentage paid the standard/highest rate application fee?
b) What number/percentage paid the lower/discounted rate application fee?
5. Of those applicants that were refused CTDA Approval (3b above)
a) What number/percentage paid the standard/highest rate application fee?
b) What number/percentage paid the lower/discounted rate application fee?
6. As of today’s date, (14 February 2022,) what is the ACTUAL current average processing time (in working days,) between, a) submission of application for CTDA Approval and b) completion of the process with decision issued to Applicant?
Interesting observation on CTDA Approval process by The Association of British HealthTech Industries (ABHI) - sorry if others have already posted.
"Findings of an industry survey on the impact of CTDA
ABHI acknowledges concerns over the existing validation process for, and the quality of, some COVID-19 tests that are currently being supplied, and support action to remove poor quality tests from the market.
However, implementation of CTDA has disproportionately and unfairly damaged the UK diagnostics industry.
An industry survey of products that were approved, or temporarily listed as exempt from the requirements of the process, showed that three quarters of large companies appear on one or both lists (approved or exempt), but fewer than half of smaller companies appear on either. Only one in ten large companies have no products listed, compared with two thirds of smaller ones.
The confused and confusing implementation of the legislation has restricted the UK supply of COVID-19 tests to a few larger companies at the expense of smaller ones. Smaller companies now feel restricted in their ability to quickly bring new products and ideas to the market. By disproportionately affecting smaller businesses, this legislation has undermined confidence in the aim of the Life Science Vision to build a robust UK diagnostics industry.
Nishan Sunthares, ABHI’s Managing Director, Diagnostics said “We have called on UK HSA to act quickly to bring clarity to the market and to allow sufficient time to properly and fairly implement this legislation in line with the needs of the NHS. Without a full and open rationale as to why their products have not been listed, manufacturers have been left confused and unsure about what they are able do with their tests. This has been compounded by delays in communications to applicants detailing precisely what is required for approval.
The supply chain has almost immediately become more fragile and less resilient. Furthermore, NHS and private laboratories must now spend time and effort transitioning to new tests in an attempt not to disrupt the NHS Winter Plan.”
8th November 2021 Ref: https://www.abhi.org.uk/resource-hub/file/13042
@JimiHendrix My GP practice is one of the largest in the county and (due to lack of resources,) they haven't even invested in a £200 dermascope let alone a £2000 poc unit! I would say that, (in the EU countries where there are no additional requirements for sale of covid tests other than the CE mark,) they would sell more units to the general public across Europe than they ever would to UK surgeries and care homes. Those that can afford it would not think twice about getting it for themselves and their extended families - people pay £2000 for top-notch coffee machines and panini presses! The unit really should be on Amazon by now (supply to EU only with UK later.) Only one account is needed for coverage across the whole of Europe with FBA (fulfilment by Amazon). As they have chosen to sell directly in this instance, I cannot understand why the device AND tests were not listed on Amazon as soon as the CE approval came through (obviously with supply limited to those EU countries where CE mark is the only requirement for sale.)
Whereas, not "where as." There are some ancient precedents for the two-word spelling but current convention is that it must not be sundered. There is no current dictionary (that I am aware of) that accepts the two-word spelling; indeed, the New Oxford Dictionary for Writers and Editors specifically cites that it must be conjoined. I thought you may find this information useful as you were so keen to highlight Sileng's grammatical error. I've never worried too much about others' punctuation as we're not all blessed with a decent education and (as long as I can understand the gist,) I've always felt that's all that matters? I must say that I thought Sileng acknowledged your criticism with true grace; he/she may not be an English expert but graciousness is an exceptional quality that many of us lack.